Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yihai Liu

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Biomaterials Research|April 12, 2022
M2-like macrophages transplantation protects against the doxorubicin-induced heart failure via mitochondrial transferYihai Liu, Mingyue Wu, Chongxia Zhong, et al.
Medicine|November 15, 2019
Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: A secondary analysis based on a single-center, retrospective, cohort studyJie Ni, Hongye Wang, Yue Li, et al.
Angiology|January 25, 2022
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery DiseaseYihai Liu, Lei Chang, Mingyue Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2021
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic miceYihai Liu, Mingyue Wu, Jiamin Xu, et al.
Lipids in Health and Disease|January 13, 2021
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityYihai Liu, Jiamin Xu, Mingyue Wu, et al.
Journal of Visualized Experiments : Jove|June 2, 2020
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In VivoYihai Liu, Wenfeng Zhang, Tingting Hu, et al.
Journal of Hypertension|August 9, 2022
The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive ratsYihai Liu, Chongxia Zhong, Jiayi Si, et al.
Frontiers in Pharmacology|May 3, 2021
Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced CardiotoxicityYihai Liu, Xuan Wei, Mingyue Wu, et al.
Biochemical and Biophysical Research Communications|November 2, 2019
MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stressYihai Liu, Yue Li, Jie Ni, et al.
International Heart Journal|July 21, 2020
Shock on Admission as a Potential Marker for ICU Mortality of Cardiac Arrest PatientsJie Ni, Yihai Liu, Mingyue Wu, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Biomaterials Research|April 12, 2022
M2-like macrophages transplantation protects against the doxorubicin-induced heart failure via mitochondrial transferYihai Liu, Mingyue Wu, Chongxia Zhong, et al.
Medicine|November 15, 2019
Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: A secondary analysis based on a single-center, retrospective, cohort studyJie Ni, Hongye Wang, Yue Li, et al.
Angiology|January 25, 2022
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery DiseaseYihai Liu, Lei Chang, Mingyue Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2021
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic miceYihai Liu, Mingyue Wu, Jiamin Xu, et al.
Lipids in Health and Disease|January 13, 2021
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityYihai Liu, Jiamin Xu, Mingyue Wu, et al.
Journal of Visualized Experiments : Jove|June 2, 2020
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In VivoYihai Liu, Wenfeng Zhang, Tingting Hu, et al.
Journal of Hypertension|August 9, 2022
The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive ratsYihai Liu, Chongxia Zhong, Jiayi Si, et al.
Frontiers in Pharmacology|May 3, 2021
Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced CardiotoxicityYihai Liu, Xuan Wei, Mingyue Wu, et al.
Biochemical and Biophysical Research Communications|November 2, 2019
MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stressYihai Liu, Yue Li, Jie Ni, et al.
International Heart Journal|July 21, 2020
Shock on Admission as a Potential Marker for ICU Mortality of Cardiac Arrest PatientsJie Ni, Yihai Liu, Mingyue Wu, et al.
Pageof 6